From: Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
 | Disease-free survival | |
---|---|---|
Variables | HR (95% CI) | P |
Age | ||
 70 and older vs. <70 | 1.062 (0.659–1.711) | 0.8038 |
Gender | ||
 Male vs. female | 1.170 (0.644–2.125) | 0.6064 |
Alcohol exposure | ||
 Ever vs. never | 1.015 (0.565–1.823) | 0.9606 |
Smoking status | ||
 Smoker vs. nonsmoker | 1.339 (0.752–2.383) | 0.3216 |
Stage | ||
 I, II, III, vs. IV | 2.356 (1.480–3.751) | 0.0003* |
SALL3 methylation | ||
 Yes vs. no | 1.914 (1.157–3.164) | 0.0114* |